Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Admission versus observation: clinically impactful or just a reimbursement shell game?
Journal: Journal of oncology practice
Published: January 29, 2015
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 15, 2014
Defining Value in Cancer Care: AVBCC 2013 Steering Committee Report.
Journal: American health & drug benefits
Published: July 04, 2014
Circulating tumor cell data: integration with imaging and serum tumor markers for metastatic breast cancer patient management.
Journal: Case reports in oncology
Published: May 08, 2014
ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 09, 2013
The NCI Community Oncology Research Program: what every clinician needs to know.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 30, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026